Citigroup’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Sell |
2,971
-18,257
| -86% | -$862K | ﹤0.01% | 3522 |
|
|
2025
Q1 | $829K | Buy |
21,228
+20,016
| +1,651% | +$782K | ﹤0.01% | 2659 |
|
|
2024
Q4 | $65.6K | Buy |
+1,212
| New | +$65.6K | ﹤0.01% | 4158 |
|
|
2024
Q1 | – | Sell |
-2,297
| Closed | -$139K | – | 4880 |
|
|
2023
Q4 | $139K | Buy |
2,297
+2,265
| +7,078% | +$137K | ﹤0.01% | 3340 |
|
|
2023
Q3 | $1.82K | Sell |
32
-571
| -95% | -$32.5K | ﹤0.01% | 4230 |
|
|
2023
Q2 | $30.8K | Sell |
603
-76,673
| -99% | -$3.91M | ﹤0.01% | 4171 |
|
|
2023
Q1 | $1.65M | Sell |
77,276
-89,041
| -54% | -$1.9M | ﹤0.01% | 1655 |
|
|
2022
Q4 | $1.75M | Buy |
166,317
+7,230
| +5% | +$75.9K | ﹤0.01% | 1610 |
|
|
2022
Q3 | $1.27M | Hold |
159,087
| – | – | ﹤0.01% | 1933 |
|
|
2022
Q2 | $835K | Buy |
+159,087
| New | +$835K | ﹤0.01% | 2214 |
|